Resound Nexia vs Yeasound RIC800

The Resound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, priced at $4,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.0/5, ranking #26 of 36 devices in the Prescription Hearing Aid category. The Nexia demonstrates clear strengths in specific performance areas. Feedback handling is excellent at 5.0/5, scoring 0.29 points above the category average—meaning users can expect reliable stability without whistling during typical daily activities. Own-voice comfort is also a highlight at 3.6/5, measuring 0.85 points above average, which may appeal to those bothered by their voice sounding hollow or boomy in other devices. However, the Nexia shows meaningful limitations in challenging listening environments. Speech in noise performance is low at 1.0/5, falling 0.96 points below the category average of 1.96/5. Speech in quiet scores 3.2/5—solid in absolute terms, though 0.11 points below the category average. Music streaming is mixed at 2.8/5, slightly above average but not a standout. At this price point, several alternatives in the same range deliver stronger overall performance, including the Phonak Sphere Infinio and Oticon Intent. The Nexia may be best suited for users who prioritize own-voice comfort and feedback-free performance over speech clarity in noisy environments, and who value the Resound ecosystem's connectivity features including iPhone and Android streaming with hands-free capability.

The Yeasound RIC800 is a mid-priced OTC hearing aid that earned an A grade with a SoundScore of 4.8/5 in our lab testing, placing it #2 among 65 OTC devices tested. At $659, this behind-the-ear rechargeable device delivers performance that significantly outpaces the category average of 3.71/5. Speech clarity is a standout strength. The RIC800 scores 4.4/5 for speech in quiet—a strong result that sits 1.63 points above the OTC category average. Speech in noise performance is more mixed at 2.4/5, though this still lands 0.93 points above the typical OTC device. Music streaming is where this device truly excels, scoring 4.3/5 and outperforming the category average by a substantial 2.38 points—making it one of the better choices for consumers who frequently stream audio from their phone. Feedback handling is excellent at 5.0/5, meaning users shouldn't encounter whistling issues during normal wear. The tradeoff comes with own-voice comfort, which scores 2.1/5—a mixed result that falls 0.41 points below the category average. Some users may notice their own voice sounds more hollow or boomy than expected. The RIC800 earned a 2025 Expert's Choice Award and supports both iPhone and Android streaming. For consumers seeking strong speech performance and exceptional streaming quality in the OTC space, this device represents a compelling option. Those particularly sensitive to own-voice quality may want to compare alternatives, but overall performance places the RIC800 among the top tier of OTC hearing aids we've tested.